CRC Research Update — August 25, 2026
Today's colorectal cancer research highlights
peritoneal
A collection of 13 issues
HIPEC combined with surgery and systemic therapy may improve outcomes in peritoneal metastases
Skip to content
The CRC Digest
▸ TREATMENT
HIPEC combined with surgery and systemic therapy may improve outcomes in peritoneal metastases
An updated meta-analysis of 12 studies (including 2 randomized controlled trials) encompassing more than 2,700 patients found that hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery and systemic therapy
Prophylactic HIPEC analyzed for survival outcomes in locally advanced colorectal cancer
Skip to content
The CRC Digest
▸ TREATMENT
Prophylactic HIPEC analyzed for survival outcomes in locally advanced colorectal cancer
A meta-analysis of 2,023 patients analyzed prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced colorectal cancer, extracting and pooling data to analyze peritoneal metastasis-free survival, disease-free survival, and overall survival.
CRC Research Update — August 15, 2026
Today's colorectal cancer research highlights
CRC Research Update — August 07, 2026
Today's colorectal cancer research highlights
CRC Research Update — July 30, 2026
Today's colorectal cancer research highlights
Phase III trial finds no survival benefit from adding chemotherapy to surgery for peritoneal metastases
Skip to content
The CRC Digest
◆ TRIAL DATA
Phase III trial finds no survival benefit from adding chemotherapy to surgery for peritoneal metastases
The CAIRO6 trial (351 patients) found that perioperative systemic therapy did not significantly improve overall survival compared to surgery alone in patients with resectable peritoneal-only metastases (44
CRC Research Update — July 17, 2026
Today's colorectal cancer research highlights
CRC Research Update — July 16, 2026
Today's colorectal cancer research highlights
CRC Research Update — July 06, 2026
Today's colorectal cancer research highlights